While reporting its financial results for the second quarter on Monday, Ligand Pharmaceuticals Inc. (LGND) said it now expects 2020 total revenues to be about $165 million and adjusted earnings per share to be $4.10, up from previous guidance for total revenues of approximately $140 million and adjusted earnings per share of $3.65.
from RTT - Earnings https://ift.tt/2XkFCxW
via IFTTT
No comments:
Post a Comment